On Tuesday, Fortis Healthcare said that its Singapore arm has completed 100% stake sale in RadLink for SGD 111 million (over Rs 530 crore) to Fullerton Healthcare Group.
Fortis Healthcare in a BSE filing said, it has received “the sum of SGD 111 million from the sale of its Singapore based RadLink-Asia Pte Ltd and its subsidiaries to Fullerton Healthcare Group Pte. With this, the deal announced on May 1, 2015 now stands completed.”
Fortis Healthcare International, a step-down subsidiary of Fortis Healthcare, on May 1, announced its decision to divest 100 percent shareholding in RadLink-Asia and its subsidiaries.
Read other Indian stock market news
